| AMPHASTAR PHARMA.DL-,0001 |
| USA |
| Gesundheit |
| US03209R1032 / A11664 |
| 29A (Frankfurt) / AMPH (NASDAQ) |
| FRA:29A, ETR:29A, 29A:GR, NASDAQ:AMPH |
| - |
| http://www.amphastar.com/ |
|
Amphastar Pharmaceuticals Inc. is a specialty pharmaceutical company dedicated to the development, manufacture, and marketing of innovative generic and proprietary injectable, inhalation, and intranas..
>Volltext.. |
| 1088.9 Mio. EUR |
| 1411.29 Mio. EUR |
| 612.79 Mio. EUR |
| 179.46 Mio. EUR |
| 94.57 Mio. EUR |
| 2 EUR |
| 556.42 Mio. EUR |
| 183.42 Mio. EUR |
| 129.01 Mio. EUR |
| 1.36 |
| -5.15% |
| -32.84% |
| - |
| - |
| - |
| - |
| AMPHASTAR |
| 27.02.26 |